ARTICLE | Clinical News
CellPro regulatory update
May 6, 1996 7:00 AM UTC
The FDA issued an approvable letter for CPRO's Ceprate SC Stem Cell Concentration System. In the letter, the agency stated that the PMA is approvable based on the submission of limited additional data...